References
- WHO. Prevention of blindness and visual impairment: Trachoma. 2009. Accessed June 25, 2009 from: http://www.who.int/blindness/causes/trachoma/en/index.html
- Kuper H, Solomon AW, Buchan J, et al. A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infect Dis 2003;3:372–381
- Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 2009;93:563–568
- Taylor HR. Trachoma grading: a new grading scheme. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 1987;64:175–181
- ITI Frequently Asked Questions. 2012. Accessed June 5, 2012 from: http://trachoma.org/iti-frequently-asked-questions
- London Declaration on Neglected Tropical Diseases, 2012. Accessed June 5, 2012 from: http://www.unitingtocombatntds.org/downloads/press/ntd_event_london_declaration_on_ntds.pdf
- Gambhir M, Basáñez MG, Burton MJ, et al. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis 2009;3(6): e462
- WHO. Trachoma control: a guide for programme managers. 2006. http://www.who.int/blindness/causes/trachoma_documents/en/index.html
- West ES, Munoz B, Mkocha H, et al. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci 2005;46:83–87
- Lietman TM, Gebre T, Ayele B, et al. The epidemiological dynamics of infectious trachoma may facilitate elimination. Epidemics 2011;3:119–124
- Burton MJ, Bowman RJ, Faal H, et al. The long-term natural history of trachomatous trichiasis in the Gambia. Invest Ophthalmol Vis Sci 2006;47:847–852
- Grassly NC, Ward ME, Ferris S, Mabey DC, Bailey RL. The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up. PLoS Negl Trop Dis 2008;2(12):e341
- Gambhir M, Basáñez MG, Turner F, et al. Trachoma: transmission, infection, and control. Lancet Infect Dis 2007;7:420–427
- Burton MJ, Holland MJ, Makalo P, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 2005;365(9467):1321–1328
- Solomon AW, Holland MJ, Burton MJ, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 2003;362(9379):198–204
- West SK, Munoz B, Mkocha H, et al. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 2001;8:137–144
- Bailey RL, Kajbaf M, Whittle HC, et al. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Epidemiol Infect 1993;111:315–324
- Dolin PJ, Faal H, Johnson GJ, et al. Trachoma in The Gambia. Br J Ophthalmol 1998;82:930–933
- WHO. Report of the 2nd Global Scientific Meeting on Trachoma, 2003: http://www.who.int/blindness/2nd%20GLOBAL%20SCIENTIFIC%20MEETING.pdf
- WHO. WHO Statistical Information System (WHOSIS), 2006: http://www3.who.int/whosis/menu.cfm?path=whosis,life
- Lietman T, Porco T, Dawson C, et al. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med 1999;5:572–576
- Jha H, Chaudary JS, Bhatta R, et al. Disappearance of trachoma from Western Nepal. Clin Infect Dis 2002;35:765–768
- Thein J, Zhao P, Liu H, et al. Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma? Ophthalmic Epidemiol 2002;9:263–269
- Dolin PJ, Faal H, Johnson GJ, et al. Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet 1997;349(9064):1511–1512
- Chidambaram JD, Lietman TM. The order is rapidly fadin’. Br J Ophthalmol 2005;89:789–790
- Stocks ME, Ogden S, Haddad D, et al. Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis. PLoS Med 2014;11:e1001605
- Harding-Esch EM, Edwards T, Mkocha H, et al. Trachoma prevalence and associated risk factors in The Gambia and Tanzania: baseline results of a cluster randomised controlled trial. PLoS Negl Trop Dis 2010;4(11): e861
- Blake IM, Burton MJ, Solomon AW, et al. Targeting antibiotics to households for trachoma control. PLoS Negl Trop Dis 2010;4(11):e862
- Basáñez MG, McCarthy JS, French MD, et al. A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl Trop Dis 2012;6:e1548
- Solomon AW, Harding-Esch E, Alexander ND, et al. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N Engl J Med 2008;358:1870–1871
- Griffin JT, Hollingsworth TD, Okell LC, et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 2010;7(8):pii: e1000324